Skip to main content
IPOAX logo

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$26.45 +$0.22 (+0.84%)

Beta 0.92: the stock has moved about 8% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) trades at $26.45. Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) invests primarily in equity securities of companies in or linked to emerging markets. Sector: Financials.

Price as of · Last analyzed: Mar 18, 2026
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) invests primarily in equity securities of companies in or linked to emerging markets. The fund aims to provide long-term capital appreciation by systematically investing in these markets.

Analyst Coverage for IPOAX: IPOAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the IPOAX film Every key number, told as a short cinematic story — just press play. ~2 min

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) Financial Services Profile

HeadquartersOverland Park, US
IPO Year1993

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) offers investors exposure to emerging market equities through a systematic investment approach. With a focus on long-term capital appreciation, the fund allocates at least 80% of its assets to companies in or linked to emerging economies, providing diversification within the financial services sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for IPOAX?

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) presents an investment opportunity centered on exposure to emerging market equities. The fund's systematic approach aims to capture long-term capital appreciation by investing at least 80% of its net assets in companies in or linked to emerging economies. A key value driver is the growth potential of emerging markets, which are expected to outpace developed markets in the coming years. Catalysts include increasing foreign investment in emerging markets and the rise of a consumer class in these regions. However, potential risks include economic and political instability in emerging markets, currency fluctuations, and the fund's beta of 0.92, indicating moderate volatility relative to the market.

Based on FMP financials and quantitative analysis

IPOAX Key Highlights

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

The fund invests at least 80% of its net assets in equity securities of companies in or linked to emerging market countries.

  • IPOAX may invest up to 100% of its total assets in foreign securities, providing broad exposure to global emerging markets.
  • The fund has a market capitalization of $2.84 billion, indicating its significance within the emerging markets equity fund landscape.
  • IPOAX has a beta of 0.92, suggesting moderate volatility compared to the overall market.
  • The fund does not offer a dividend yield, focusing instead on capital appreciation.

Who Are IPOAX's Competitors?

IPOAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BBHLX BBH Partner Fund - International Equity Class Institutional $22.74 +0.18% $2.53B —
BFGFX Baron Focused Growth Fund Retail Shs $64.00 +3.61% $3.08B —
BFGIX Baron Focused Growth Fund Inst Shs $67.35 +3.60% $3.09B —
JORNX Janus Henderson Global Select Fund - T Shares $21.55 +1.32% $2.71B —
JORRX Janus Henderson Global Select Fund Class R $20.90 +1.36% $2.59B —
BLK BlackRock, Inc. $1066.45 +0.64% $165B 51 5-pillar
BX Blackstone Inc. $111.64 -0.09% $136B 68 5-pillar
APOS Apollo Global Management, Inc. $25.59 0.00% $74.8B 56 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IPOAX's Key Strengths?

Exposure to high-growth emerging markets.

  • Systematic investment approach.
  • Experienced management team.
  • Diversified portfolio.

What Are IPOAX's Weaknesses?

Higher volatility compared to developed markets.

  • Exposure to political and economic instability in emerging markets.
  • Currency risk.
  • Dependence on emerging market performance.

What Are the Key Risks for IPOAX?

Economic and political instability in emerging markets.

  • Currency fluctuations.
  • Geopolitical risks.
  • Increased competition in the asset management industry.
  • Market volatility affecting emerging market equities.

What Threats Does IPOAX Face?

  • Increased competition from other emerging market funds.
  • Geopolitical risks.
  • Changes in government regulations.
  • Economic slowdown in emerging markets.

What Are IPOAX's Competitive Advantages?

  • Established track record in emerging market investing.
  • Systematic investment approach based on proprietary research.
  • Experienced investment management team.
  • Diversified portfolio across multiple emerging market countries and sectors.

What Does IPOAX Do?

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) is an actively managed fund focused on providing investors with exposure to the growth potential of emerging markets. The fund invests primarily in equity securities, with a significant emphasis on common stock, of companies located in or economically tied to emerging market countries. Under normal circumstances, at least 80% of the fund's net assets are allocated to these investments. The fund's strategy allows for investment in depositary receipts of foreign issuers and permits up to 100% of its total assets to be held in foreign securities, showcasing a global investment approach within the emerging markets sphere. Furthermore, the fund retains the flexibility to invest up to 20% of its net assets in companies not directly associated with emerging markets, providing a degree of diversification beyond its primary focus. IPOAX operates within the asset management industry, catering to investors seeking long-term capital appreciation through exposure to the dynamic economies of emerging markets. The fund's systematic approach aims to identify and capitalize on opportunities within these markets, while also managing risk through diversification and active portfolio management. IPOAX, with its $2.84 billion market capitalization, is a significant player in the emerging markets equity fund space.

What Products and Services Does IPOAX Offer?

  • Invests in equity securities of companies in emerging market countries.
  • Focuses primarily on common stock.
  • May invest in depositary receipts of foreign issuers.
  • Can allocate up to 100% of its assets in foreign securities.
  • May invest up to 20% of its net assets in companies not linked to emerging markets.
  • Aims for long-term capital appreciation.

How Does IPOAX Make Money?

  • Generates revenue through management fees based on assets under management (AUM).
  • May earn performance-based fees if the fund outperforms its benchmark.
  • Invests in equity securities to generate capital gains.
  • Reinvests dividends and other income to enhance returns.

What Industry Does IPOAX Operate In?

Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) operates within the asset management industry, specifically targeting emerging markets equities. The industry is characterized by increasing demand for emerging market investments, driven by the potential for higher growth compared to developed economies. The competitive landscape includes funds such as BBHLX (BlackRock Health Sciences Opportunities Portfolio Investor A), BFGFX (BlackRock Global Allocation Fund Investor A), BFGIX (BlackRock Global Allocation Fund Institutional), JORNX (JPMorgan US Research Enhanced Equity Fund Class R6), and JORRX (JPMorgan US Research Enhanced Equity Fund Class R5), each with varying investment strategies and focuses. IPOAX differentiates itself through its systematic investment approach and focus on long-term capital appreciation.

Who Are IPOAX's Key Customers?

  • Institutional investors seeking exposure to emerging market equities.
  • Retail investors looking for long-term capital appreciation.
  • Financial advisors seeking diversified investment options for their clients.
  • Pension funds and endowments investing in emerging markets.
Model self-rating on this text: 83% (not a measure of the evidence) Updated: Mar 18, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is a fund, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 42 snapshots

2026-08-23 44
2026-08-31 44
2026-09-08 44
2026-09-16 44
2026-09-24 44
2026-10-04 44
2026-10-05 44

What changed?

The score has stayed at 44.

Over the same 30 days the stock moved +0.4%.

IPOAX Financials

Bull Case vs Bear Case

Bull Case

  • Exposure to high-growth emerging markets.
  • Systematic investment approach.
  • Experienced management team.
  • Diversified portfolio.

Bear Case

  • Higher volatility compared to developed markets.
  • Exposure to political and economic instability in emerging markets.
  • Currency risk.
  • Dependence on emerging market performance.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

IPOAX Latest News

No recent news available for IPOAX.

IPOAX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IPOAX.

Price Targets

Wall Street price target analysis for IPOAX.

IPOAX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IPOAX; grades run from A+ (80-100) to F (below 30).

Macquarie Systematic Emerging Markets Equity Fund A Financials Stock: Key Questions Answered

What do analysts say about IPOAX stock?

As of 2026-03-18, AI analysis for IPOAX is pending, so there is no current analyst consensus available. However, it is important to consider the fund's investment strategy, which focuses on emerging market equities. Emerging markets offer potential for high growth but also come with increased volatility and risk.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and may be subject to change.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis